Yang Lab

Programing, Reprogramming & Psychiatric Diseases

Research

nan yang mssm nueroscience

A striking feature of the nervous system is its enormous cellular diversity. The Yang laboratory seeks to understand how the nervous system achieves its extraordinary cellular and functional complexity. To study these fundamental questions and associated brain disorders, we direct the differentiation of stem cells into diverse types of brain cells such as neurons, astrocytes, oligodendrocytes and microglia. Although reductionist in nature, this system allows us to reconstitute human nervous system in a dish and elucidate the underlying signaling interactions, cellular information processing, and gene expression regulation that govern basic activities of cells and coordinates all cell actions.

Our work aims at developing approaches and employ state-of-the-art stem cell biology, genome engineering, and neuroscience approaches to understand and modulate the neuronal function in neuropsychiatric diseases. We use 2D and 3D organoid models to understanding how disease associated risk variants in contribute to pathogenesis of multiple neuropsychiatric disorders including autism spectrum disorder, bipolar disorder and schizophrenia.

Contact Us

Yang Laboratory
Nan Yang, PhD
Assistant Professor, Neuroscience
Location
Lab: Icahn 13-52
Office: Icahn 13-20B
Phone
Office: 212-659-8288
Email: nan.yang1@mssm.edu

Areas of Investigation

Cell fate in the nervous system

Human induced neurons in mouse brain

We have pioneered the transcription factor mediated (trans-)differentiation of non-neural human cells, including fibroblasts and pluripotent stem cells, into multiple neural lineages including neurons and glial cells. Our goal is to investigate the fundamental events underlying the progression of cell fate specification and ultimately to recreate the cell types of the central nervous system from human pluripotent stem cells for research and potential use in clinical therapies. 

Modeling human brain development and disease

One of the most intriguing applications of human pluripotent stem cells is the possibility to recapitulate and study key aspects of human brain development. Our group team up with the Seaver Autism Center at Mount Sinai to investigate the changes caused by autism associated rare mutations at cellular and molecular levels in multiple brain regions using 3D brain organoid models and in different neuronal types with particular interests on epigenetic modifications and synaptic functions using induced neurons.

Non-coding regions and human psychiatric diseases

Advances in human genetics and next-generation sequencing have permitted the identification of a stunning number of genetic variants that are linked to autism spectrum disorder (ASD), providing a platform for unraveling the causal chain of events that result in the disorder. However, the availability of data is not synonymous with the presence of meaning. Indeed, the challenge researchers are facing now is the derivation of biological meaning post-GWAS. Particularly, an increasing number of risk-associated variants are found in non-coding sequences. We use stem cell modeling system, genome engineering, CRISPR-mediated epigenetic editing, and state-of-the-art single-cell sequencing technology to determine the molecular impact of such non-coding sequence alterations.

Publications

2019

Nobuta H, Yang N, Ng YH, Marro SG, Sabeur K, Chavali M, Stockley JH, Killilea DW, Walter PB, Zhao C, Huie P Jr, Goldman SA, Kriegstein AR, Franklin RJM, Rowitch DH, Wernig M. Oligodendrocyte Death in Pelizaeus-Merzbacher Disease Is Rescued by Iron Chelation. Cell Stem Cell. 2019 Oct 3;25(4):531-541

Marro SG, Chanda S, Yang N, Janas JA, Valperga G, Trotter J, Zhou B, Merrill S, Yousif I, Shelby H, Vogel H, Kalani MYS, Südhof TC, Wernig M. Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons. Neuron. 2019 Aug 21;103(4):617-626.

2017

Yang N, Chanda S, Marro S, Ng YH, Janas JA, Haag D, Ang CE, Tang Y, Flores Q, Mall M, Wapinski O, Li M, Ahlenius H, Rubenstein JL, Chang HY, Buylla AA, Südhof TC, Wernig M. Generation of pure GABAergic neurons by transcription factor programming. Nat Methods. 2017 Jun;14(6):621-628

2014

Marro S, Yang N. Transdifferentiation of mouse fibroblasts and hepatocytes to functional neurons. Methods Mol Biol. 2014;1150:237-46 (book chapter)

2013

Yang N, Wernig M. Harnessing the stem cell potential: a case for neural stem cell therapy. Nat Med. 2013 Dec;19(12):1580-1.



Yang N, Zuchero JB, Ahlenius H, Marro S, Ng YH, Vierbuchen T, Hawkins JS, Geissler R, Barres BA, Wernig M. Generation of oligodendroglial cells by direct lineage conversion. Nat Biotechnol. 2013 May;31(5):434-9.

2011

Yang N, Ng YH, Pang ZP, Südhof TC, Wernig M. Induced neuronal cells: how to make and define a neuron. Cell Stem Cell. 2011 Dec 2;9(6):517-25.


Marro S, Pang ZP, Yang N, Tsai MC, Qu K, Chang HY, Südhof TC, Wernig M. Direct Lineage Conversion of Terminally Differentiated Hepatocytes to Functional Neurons. Cell Stem Cell. 2011 2011 Oct 4;9(4):374-82.


Pang ZP*, Yang N*, Vierbuchen T*, Ostermeier A, Fuentes DR, Yang TQ, Citri A, Sebastiano V, Marro S, Südhof TC, Wernig M. Induction of human neuronal cells by defined transcription factors. Nature. 2011 May 26;476(7359):220-3.

We welcome postdoctoral applicants who are interested in applying pluripotent stem cell models to address basic mechanistic questions in the development, function and disease of human nervous system. Applicants with expertise in genomics, differentiation of pluripotent stem cells, or neural development/neuroscience are of particular interest at this time. Interested candidates should send their CV and names/contact information of 3 potential references to Dr. Nan Yang.